Clinical trial
Open Randomized Single Centre Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With Severe Lung Injury Secondary to COVID-19
NCT04341038 is registered in ClinicalTrials.gov with Hospital Universitari de Bellvitge as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open Randomized Single Centre Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With Severe Lung Injury Secondary to COVID-19
- Lead sponsor
- Hospital Universitari de Bellvitge
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- April 1, 2020
- Completion date
- July 1, 2020
- Enrollment
- 84 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.